Ocular presentation, therapeutic management and previously prescribed drugs in 46 patients with vaccine-associated rejection
| N=46 | % | |
| Ocular presentation | ||
| Reduced vision | 18 | 39.13 |
| Corneal oedema | 9 | 19.57 |
| Anterior chamber cells | 8 | 17.39 |
| Descemet folds | 8 | 17.39 |
| Conjunctival hyperaemia or injection | 7 | 15.22 |
| Keratic precipitates | 7 | 15.22 |
| Corneal thickening | 2 | 4.35 |
| Others | 5 | 10.87 |
| Drugs prescribed | ||
| Corticosteroids (Topical) | 24 | 52.17 |
| Dexamethasone | 7 | 15.22 |
| Difluprednate | 3 | 6.52 |
| Prednisolone acetate 1% | 7 | 15.22 |
| Unspecified | 7 | 15.22 |
| Corticosteroids (oral) | 4 | 8.70 |
| Prednisone | 3 | 6.52 |
| Unspecified | 1 | 2.17 |
| Corticosteroids (subconjunctival injection) | 5 | 10.87 |
| Dexamethasone | 2 | 4.35 |
| Prednisolone acetate 1% | 1 | 2.17 |
| Betamethasone | 1 | 2.17 |
| Unspecified | 1 | 2.17 |
| Drugs at presentation | ||
| Corticosteroids | 11 | 23.91 |
| Methylprednisolone acetate | 1 | 2.17 |
| Dexamethasone | 7 | 15.22 |
| Budesonide | 1 | 2.17 |
| Corticosteroids (unspecified) | 1 | 2.17 |
| Hydrocortisone | 1 | 2.17 |
| Other immunosuppressants | 5 | 10.87 |
| Cyclosporine | 2 | 4.35 |
| Adalimumab | 1 | 2.17 |
| Others (unspecified) | 2 | 4.35 |
| Glaucoma medications | 10 | 21.74 |
| Brimonidine | 2 | 4.35 |
| Monoprost | 2 | 4.35 |
| Xalacom (latanoprost+timolol maleate) | 2 | 4.35 |
| Cosopt (dorzolamide+timolol) | 2 | 4.35 |
| Latanoprost | 1 | 2.17 |
| Timolol maleate | 1 | 2.17 |
| Antimicrobial agents | 4 | 8.70 |
| Fluconazole | 2 | 4.35 |
| Valacyclovir | 1 | 2.17 |
| Antibiotics (unspecified) | 1 | 2.17 |